December 19, 2022
Altis Biosystems Awards New Research Funding to Plakous Therapeutics, Inc.
Altis Biosystems, Inc., developer of RepliGut®, Awards New Research Funding to Plakous Therapeutics, Inc
July 13, 2022
Altis Biosystems to Award a Fully Funded Pilot Project
Altis Biosystems, Inc., developer of RepliGut®, announces a Research Funding Initiative
June 22, 2022
Assessing Drug-induced Gut Toxicity In Vitro
This webinar addresses the challenges of assessing drug-induced gut toxicity in vitro and introduces the Altis RepliGut Planar Model
May 12, 2022
Altis named one of the top 20 most innovative organ-on-a-chip companies in the world.
Top 20 most innovative organ-on-a-chip companies